Table 3.
CT findings of COVID-19 patients confirmed by nucleic acid test (n=70)
| Imaging features | n (%) |
|---|---|
| Lung involvement | |
| Unilateral | 11 (15.7) |
| Bilateral | 59 (84.3) |
|
| |
| Distribution | |
| Peripheral | 39 (55.7) |
| Peripheral and central | 31 (44.3) |
|
| |
| Number | |
| Single lesion | 14 (20.0) |
| Two lesions | 9 (12.9) |
|
| |
| Multiple lesions | 47 (67.1) |
|
| |
| Density | |
| Ground glass density | 27 (38.6) |
| Consolidation density | 2 (2.8) |
| Mixed density | 41 (58.6) |
|
| |
| Other signs | |
| Pleural thickening | 12 (17.1) |
| Pleural effusion | 4 (5.7) |
| Mediastinal lymph node enlargement | 2 (2.8) |
CT, computed tomography; COVID-19, coronavirus disease 2019.